The Center of ALS and other MND (CeSLA) of the University Hospital of Geneva comprises a unique infrastructure bringing together all medical and para-medical specialties implicated in the treatment of patients with motor neuron disease. Thus, we are able to provide optimal standard of care for this population, and offer state-of-the art diagnostic and therapeutic approaches, including genetic therapies for ALS and adult SMA. Our center is following patients from all over Switzerland, and is the main reference center for MND in the French speaking part of the country, as well as patients from France.
| University Hospital of Geneva | |
|---|---|
| Foundation year | 2010 |
| Director | PD Dr Annemarie Hübers |
| Principal investigator | PD Dr Annemarie Hübers |
| Contact information | |
|---|---|
| Address | HUG, Rue Gabrielle-Perret-Gentil 4, CH-1205 Genève |
| Contact | Madame Marjorie Bel Henichier |
| Phone | 079 553 77 48 / 022 37 23 490 |
| Marjorie.BelHenicher@hcuge.ch | |
| Website | Visit the website |
Publications
For other publications, see: https://www.hug.ch/neurologie/centre-sla
Restricted information
| Serving population | |
|---|---|
| Serving population | Switzerland, partly France |
| Patient resources | |
|---|---|
| Population based register | Yes |
| Clinic based register | Yes |
| Geographically matched controls | No |
Banks
There are no banks for this centre
| Research activities | |
|---|---|
| Clinical management research | No |
| Neuro epidemiology | Yes |
| Neuro physiology | Yes |
| Neuro imaging | Yes |
| Neuro psychology | Yes |
| Neuro pathology | No |
| Genomics | Yes |
| Transcriptomics | No |
| Metabolomics | No |
Clinical Trials - Industry sponsored
| Name | Type | Patients |
|---|---|---|
| Mitsubishi Tanabe MT-1186-A02 | Phase III |
Clinical Trials - Investigator initiated
| Name | Type | Patients |
|---|---|---|
| Tideglusib for the treatment of patients with ALS TIDALS | Phase II |